StoryFunding
Pivot Bio raises $430M Series D co-led by DCVC and Temasek
Pivot Bio closed a $430 million Series D co-led by DCVC and Temasek, taking total equity raised past $600 million. The money was to speed up microbial products that let corn, wheat and rice get nitrogen from soil bacteria instead of synthetic fertilizer.
- Series D co-led by DCVC and Temasek; cumulative equity past $600 million.
- Funding to accelerate microbial nitrogen replacement for synthetic fertilizer in corn, wheat and rice.
- Targets $60 billion annual synthetic nitrogen fertilizer market.